COVID-19 Update: We are currently shipping orders daily. However, due to transit disruptions in some geographies, deliveries may be delayed. To provide all customers with timely access to content, we are offering 50% off Science and Technology Print & eBook bundle options. Terms & conditions.
Drug Repurposing in Cancer Therapy - 1st Edition - ISBN: 9780128196687, 9780128199039

Drug Repurposing in Cancer Therapy

1st Edition

Approaches and Applications

Editors: Kenneth To William Cho
Paperback ISBN: 9780128196687
eBook ISBN: 9780128199039
Imprint: Academic Press
Published Date: 27th July 2020
Page Count: 458
Sales tax will be calculated at check-out Price includes VAT/GST
Price includes VAT/GST

Institutional Subscription

Secure Checkout

Personal information is secured with SSL technology.

Free Shipping

Free global shipping
No minimum order.


Drug Repurposing in Cancer Therapy: Approaches and Applications provides comprehensive and updated information from experts in basic science research and clinical practice on how existing drugs can be repurposed for cancer treatment. The book summarizes successful stories that may assist researchers in the field to better design their studies for new repurposing projects. Sections discuss specific topics such as in silico prediction and high throughput screening of repurposed drugs, drug repurposing for overcoming chemoresistance and eradicating cancer stem cells, and clinical investigation on combination of repurposed drug and anticancer therapy.

Cancer researchers, oncologists, pharmacologists and several members of biomedical field who are interested in learning more about the use of existing drugs for different purposes in cancer therapy will find this to be a valuable resource.

Key Features

  • Presents a systematic and up-to-date collection of the research underpinning the various drug repurposing approaches for a quick, but in-depth understanding on current trends in drug repurposing research
  • Brings better understanding of the drug repurposing process in a holistic way, combining both basic and clinical sciences
  • Encompasses a collection of successful stories of drug repurposing for cancer therapy in different cancer types


Cancer researchers, medical scientists, clinicians, graduate students, pharmacologists

Table of Contents

  1. Drug repurposing for cancer therapydan introduction
    2. A ligand-centric approach to identify potential drugs for repurposing: case study with aurora kinase inhibitors
    3. Machine learning strategies for identifying repurposed drugs for cancer therapy
    4. Unveiling potential anticancer drugs through in silico drug repurposing approaches
    5. Increasing opportunities of drug repurposing for treating breast cancer by the integration of molecular, histological, and systemic approaches
    6. The success story of drug repurposing in breast cancer
    7. A personalized medicine approach to drug repurposing for the treatment of breast cancer molecular subtypes
    8. Successful stories of drug repurposing for cancer therapy in hepatocellular carcinoma
    9. Stories of drug repurposing for pancreatic cancer treatmentdPast, present, and future
    10. Animal models and in vivo investigations for drug repurposing in lung cancer
    11. Identification of chemosensitizers by drug repurposing to enhance the efficacy of cancer therapy
    12. Drugs repurposed to potentiate immunotherapy for cancer treatment
    13. Nanoparticle-based formulation for drug repurposing in cancer treatment
    14. Nanotechnological approaches in cancer: the role of celecoxib and disulfiram
    15. Clinical trials on combination of repurposed drugs and anticancer therapies


No. of pages:
© Academic Press 2020
27th July 2020
Academic Press
Paperback ISBN:
eBook ISBN:

About the Editors

Kenneth To

Prof. Kenneth To is currently an Associate Professor in the Chinese University of Hong Kong. He received post-doctoral training at the National Cancer Institute, National Institute of Health, USA, investigating the mechanisms of multidrug resistance and cancer epigenetics. After he became an independent investigator, his research interests focus on the development of novel strategies to overcome drug resistance to classical cytotoxic anticancer drugs as well as molecular targeted cancer therapeutics. He has served as Guest Associate Editor (Frontiers in Oncology & Frontiers in Genetics), Consulting Editor (Pharmacology Research and Perspectives) and Editorial Board Member in 4 other journals in the fields of cancer research and pharmacology. He published more than 100 peer-reviewed articles in highly ranked scientific journals in cancer biology and pharmacology.

Affiliations and Expertise

Associate Professor, Chinese University of Hong Kong

William Cho

Dr. William Cho is a Biomedical Scientist in Queen Elizabeth Hospital. His main research interests have been focusing on cancer researches. He is a Chartered Scientist granted by the Science Council (UK), a Registered Chinese Medicine Practitioner (HK), Guest Professor of some universities and a Fellow Member of several institutes, including the Institute of Biomedical Science (UK), Hong Kong Institute of Biomedical Science and Hong Kong Society for Molecular Diagnostic Sciences. Dr. Cho has published about 300 peer-reviewed papers (Lancet Oncology, Nature Communications, PNAS, etc.) covering cancer biomarkers, anti-cancer drugs, proteomics, microRNAs, Chinese medicine and over a dozen of books.

Affiliations and Expertise

Queen Elizabeth Hospital, Hong Kong

Ratings and Reviews